We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GlaxoSmithKline and OncoMed Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics

News   Dec 11, 2007

 
GlaxoSmithKline and OncoMed Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics
 
 
 

RELATED ARTICLES

Nanoscaffold Developed to Enhance CNS Stem Cell Therapy

News

Biodegradable nanoscaffolds have been developed to overcome a host of challenges in stem cell therapies for CNS diseases and injuries

READ MORE


Embryonic 'Signaling Memory' Permanently Alters Differentiation Pathway

News

Embryonic cells retain a memory of the chemical signals to which they are exposed. Without these memories, cells fail to organize into distinct tissue types.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE